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Background: Atherosclerosis(AS) is one of the most principal causes of 
cardiovascular diseases which seriously threatens the public health throughout the 
world. Cardiovascular diseases are expected to be the main cause of death globally for 
the recent years owing to the rising incidence of obesity and diabetes in the world.  
Coronary  artery  atherosclerosis has been a major focus for clinical  investigation  
and considerable strides have been made in the development of programmes to 
prevent and treat the clinical manifestations of this disease. Therefore, more and more 
focus have been put on searching for new drugs of atheroclerosis. 
It is widely reported that atherosclerosis begins in childhood. Atherosclerosis is  
a process that starts early in life and progresses silently and slowly for decades, 
usually only manifesting clinically in middle age. Since childhood risk factors  
persist into adulthood, the lifelong burden of a dyslipidaemic trait and concomitant 
conditions such as obesity，hypertension，hyperlipidemia and diabetes has a major 
impact on the silent  phase  of  this  disease. Once the atherosclerotic plaque has 
fromed, there is barely effective clinical treatment to remove it. So it seems more and 
more important to find a way to prevent it. 
PPAR-α has become an important research target of atherosclerosis due to its 
regulation of calorie metabolism, inflammation and endothelial function. The 
endogenous PPAR-α ligand oleoyethanolamide (OEA) has its potential for a 
anti-atherosclerosis drugs,as the exsited PPAR-α synthesis ligands have become 
first-line drugs for clinical treatment of cardiocascular disease.  
Purpose: The purpose of our study is to investigate the effects of OEA on the 
evolution of atherosclerosis response and different animal models .  
Methods: Human umbilical vein endothelial cells(HUVECs) apoptosis was 
detected by AnnexinⅤ/PI-FTIC staining and flow cytometer, and VSMC migration 
assays were performed with tranwell chamber. The expression level of mRNA and 
protein were detected by quantitative real-time PCR and  ELISA. Bouin’s 
solution-fixed abdominal aorta tissues were embedded in paraffin and cut into 4 μm thick sections 
for histomorphological examination. After drying, abdominal aorta tissue section slides were 















triglyceride (TG) were determined using an Auto Chemistry Analyzer. 
Results: Data showed that, in HUVEC and VSMC cells, OEA reduces cell 
apoptosis and migration. In RAW 246.7 cells, OEA decreased the expression levels of 
inflammatory cytokines, and LPS-induced LDL oxidant reverses by OEA. Furthermore, 
OEA prevents the formation of atherosclerotic plaques in aorta lesion rats and 
ApoE(-/-) mice. 
Conclusion：The data suggests that OEA played a certain role on preventing the 
the evolution atherosclerosis through activation of PPAR-α . 
Keywords: oleoyethanolamide; Peroxisome Proliferator-activated Receptors; 
atherosclerosis ;Human umbilical vein endothelial cells;rat vascular smooth muscle 
cellS; inflammation; atheroslerosis following balloon catheter injury of hyperlipidemia rats; 
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